Abexinostat (Compound)

Compound:

abexinostat (51417e52-26ba-484f-a9df-200fde25f190)

Synonyms:ABEXINOSTAT, 783355-60-2, PCI-24781, PCI 24781, CRA-024781, CRA 024781, CRA-02478, Abexinostat [USAN], 3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide, Abexinostat [USAN:INN]

Pubchem:PUBCHEM:11749858

Id:5e3bde7f-171a-57c5-864b-ebf665058468

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Abexinostat's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Abexinostat.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Abexinostat.

Results found

Linked to

	Label	Description
	BRD-K12867552-001-04-7 Substance (Entity type)	A Substance
	Abexinostat negatively regulates KRT13 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat positively regulates CYFIP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat negatively regulates HMGB2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat negatively regulates TLCD3A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	midazolam in similarity relationship with Abexinostat Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat bioactivity Histone deacetylase 6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Abexinostat bioactivity Histone deacetylase 1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pracinostat in similarity relationship with Abexinostat Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Abexinostat bioactivity Histone deacetylase 3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

BRD-K12867552-001-04-7

Substance (Entity type)

A Substance

Abexinostat negatively regulates KRT13

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Abexinostat positively regulates CYFIP2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Abexinostat negatively regulates HMGB2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Abexinostat negatively regulates TLCD3A

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

midazolam in similarity relationship with Abexinostat

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Abexinostat bioactivity Histone deacetylase 6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Abexinostat bioactivity Histone deacetylase 1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Pracinostat in similarity relationship with Abexinostat

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

Abexinostat bioactivity Histone deacetylase 3

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.